AR056005A1 - Cianopirrol - sulfonamidas moduladores del receptor de progesterona y usos de los mismos - Google Patents
Cianopirrol - sulfonamidas moduladores del receptor de progesterona y usos de los mismosInfo
- Publication number
- AR056005A1 AR056005A1 ARP060103257A ARP060103257A AR056005A1 AR 056005 A1 AR056005 A1 AR 056005A1 AR P060103257 A ARP060103257 A AR P060103257A AR P060103257 A ARP060103257 A AR P060103257A AR 056005 A1 AR056005 A1 AR 056005A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- aryl
- alkenyl
- alkynyl
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title 2
- 229960003387 progesterone Drugs 0.000 title 1
- 239000000186 progesterone Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 16
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 125000004426 substituted alkynyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- -1 (CHmXn) zCHpXq Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Los compuestos de la presente son utiles para la contracepcion y terapia de reemplazo hormonal. Reivindicacion 1: Un compuesto que tiene la estructura de la formula (1), o su sal aceptable para uso farmacéutico donde: R1 se selecciona del grupo que consiste en: H, CN, SO2-alquilo C1-6, SO2-cicloalquilo C3-8, SO2-alquilo C1-6 sustituido, SO2-arilo, SO2-arilo sustituido, SO2-heteroarilo, SO2-heterociclo, SO2-alquenilo C3-6, SO2-alquinilo C3-6, SO2-alquenilo C3-6 sustituido, SO2-alquinilo C3-6 sustituido, C(O)-alquilo C1-6, C(O)-cicloalquilo C3-8, C(O)-alquilo C1-6 sustituido, C(O)-arilo, C(O)-arilo sustituido, C(O)-heteroarilo, C(O)-heterociclo, C(O)-alquenilo C3-6, C(O)-alquinilo C3-6, C(O)-alquenilo C3-6 sustituido, C(O)-alquinilo C3-6 sustituido, C(O)O-alquilo C1-6, C(O)O-cicloalquilo C3-8, C(O)O-alquilo C1-6 sustituido, C(O)O-arilo, C(O)O-arilo sustituido, C(O)O-heteroarilo, C(O)O-heterociclo, C(O)O-alquenilo C3-6, C(O)O-alquinilo C3-6, C(O)O-alquenilo C3-6 sustituido, C(O)O- alquinilo C3-6 sustituido, C(O)NH-alquilo C1-6, C(O)NH-cicloalquilo C3-8, C(O)N-di-ciclolquilo C3-8, C(O)N-di-alquilo C1-6, C(O)N-di-alquilo C1-6 disustituido, C(O)NH-alquilo C1-6 sustituido, C(O)NH-arilo, C(O)N-di-arilo, C(O)NH-arilo sustituido, C(O)N-diarilo, C(O)NH-heteroarilo, C(O)NH-heterociclo, C(O)N-diheteroarilo, C(O)N-diheterociclo, C(O)NH-alquenilo C3-6, C(O)NH-alquinilo C3-6, C(O)NH-alquenilo C3-6 sustituido y C(O)NH-alquinilo C3-6 sustituido; o R1 es un grupo de union a una segunda estructura de formula (1) para formar un dímero de formula (1), dicho grupo de union se selecciona del grupo que consiste en C(O)- y S(O)2-; R2 se selecciona del grupo que consiste en H, alquilo C1-6, alquilo C1-6 sustituido, cicloalquilo C3- 6, SO2-alquilo y SO2-alquilo sustituido; con la condicion de que por lo menos uno de R1 o R2 contengan un grupo que tiene un enlace SO2- al N o R1 es un grupo de union S(O)2-; o R1 y R2 se unen para formar -(C(R8)a(R9)b)c-SO2-(C(R8)d(R9)e)f-; R8 y R9 son, independientemente, H, halogeno, o alquilo C1-6; a y b son, independientemente, 0 a 2, con la condicion de que a + b = 2; d y e son, independientemente, 0 a 2, con la condicion de que a + b = 2; c y f son, independientemente, 0 a 5, con la condicion de que uno de c o f sea mayor que 0; R3,. R4, R5 y R6 se seleccionan independientemente del grupo que consiste en H, halogeno, CN, alquilo C1-6, alquilo C1-6 sustituido, (CHmXn)zCHpXq, cicloalquilo C3-6, O-alquilo C1-6, O-alquilo C1-6 sustituido, O-(CHmXn)zCHpXq, arilo, heteroarilo, heterociclo, arilo sustituido, heteroarilo sustituido, heterociclo sustituido; X es halogeno; m y n son independientemente, 0 a 2, con la condicion de que m + n = 2; p y q son, independientemente, 0 a 3, con la condicion de que p + q = 3; y z es 0 a 10; R7 se selecciona del grupo que consiste en H, alquilo C1-6, C(O)O-alquilo C1-6, alquenilo C2-6, alquinilo C2-6, alquilo C1-6 sustituido, cicloalquilo C3-6 y cicloalquilo C3-6 sustituido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70400905P | 2005-07-29 | 2005-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056005A1 true AR056005A1 (es) | 2007-09-12 |
Family
ID=37309001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103257A AR056005A1 (es) | 2005-07-29 | 2006-07-27 | Cianopirrol - sulfonamidas moduladores del receptor de progesterona y usos de los mismos |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7291643B2 (es) |
| EP (1) | EP1910285A1 (es) |
| JP (1) | JP5185114B2 (es) |
| KR (1) | KR20080031915A (es) |
| CN (1) | CN101233104A (es) |
| AR (1) | AR056005A1 (es) |
| AU (1) | AU2006275833B2 (es) |
| BR (1) | BRPI0614412A2 (es) |
| CA (1) | CA2612977A1 (es) |
| CR (1) | CR9627A (es) |
| EC (1) | ECSP088147A (es) |
| GT (1) | GT200600336A (es) |
| HN (1) | HN2008000135A (es) |
| IL (1) | IL188314A (es) |
| MX (1) | MX2008001338A (es) |
| NO (1) | NO20076683L (es) |
| PE (1) | PE20070404A1 (es) |
| RU (1) | RU2007148077A (es) |
| SA (1) | SA06270246B1 (es) |
| TW (1) | TW200734302A (es) |
| UA (1) | UA92500C2 (es) |
| WO (1) | WO2007016212A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
| PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
| TW200848019A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
| TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| US20090170823A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception |
| WO2014071298A1 (en) | 2012-11-05 | 2014-05-08 | Nant Holdings Ip, Llc | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680413A (en) | 1986-01-17 | 1987-07-14 | Nippon Soda Co., Ltd. | Process for the production of 3-phenyl-4-cyanopyrroles |
| US5310938A (en) | 1987-07-29 | 1994-05-10 | American Cyanamid Company | Substituted arylpyrrole compounds |
| EP0339342A1 (de) | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
| GB8903592D0 (en) | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| DE4036645A1 (de) | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
| JP2699024B2 (ja) | 1990-11-22 | 1998-01-19 | 富士写真フイルム株式会社 | 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
| US5236925A (en) | 1991-10-24 | 1993-08-17 | American Home Products Corporation | Fused pyrimidines as angiotensin II antagonists |
| US5187168A (en) | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
| WO1994017059A1 (fr) | 1993-01-29 | 1994-08-04 | Nippon Soda Co., Ltd. | Derive heterocyclique |
| DE69635857T2 (de) | 1995-06-07 | 2006-10-19 | Nippon Shinyaku Co., Ltd. | Pyrrolderivate und medizinische zusammensetzung |
| US6013421A (en) | 1996-07-19 | 2000-01-11 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material and image-forming method |
| US20010007867A1 (en) | 1999-12-13 | 2001-07-12 | Yuhpyng L. Chen | Substituted 6,5-hetero-bicyclic derivatives |
| US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| KR20030080087A (ko) | 2001-03-09 | 2003-10-10 | 화이자 프로덕츠 인코포레이티드 | 항염증제로서의 트리아졸로피리딘 |
| JP2004526727A (ja) | 2001-03-09 | 2004-09-02 | ファイザー・プロダクツ・インク | ベンゾイミダゾール抗炎症化合物 |
| DE60205974T2 (de) | 2001-04-04 | 2006-06-29 | Pfizer Products Inc., Groton | Neue Benzotriazole mit entzündungshemmender Wirkung |
| HRP20050529A2 (en) | 2002-11-11 | 2006-08-31 | Bayer Healthcare Ag | Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| EP1594438B1 (fr) | 2003-02-12 | 2013-07-17 | L'Oréal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères |
| ES2306140T3 (es) | 2004-04-27 | 2008-11-01 | Wyeth | Biarilos ciclicos de carbamato y tiocarbamato que contienen cianopirrol y procedimientos para su preparacion. |
| GT200500185A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
-
2006
- 2006-07-26 PE PE2006000915A patent/PE20070404A1/es not_active Application Discontinuation
- 2006-07-27 BR BRPI0614412A patent/BRPI0614412A2/pt not_active IP Right Cessation
- 2006-07-27 WO PCT/US2006/029125 patent/WO2007016212A1/en not_active Ceased
- 2006-07-27 UA UAA200801075A patent/UA92500C2/ru unknown
- 2006-07-27 EP EP06774705A patent/EP1910285A1/en not_active Withdrawn
- 2006-07-27 CN CNA2006800277588A patent/CN101233104A/zh active Pending
- 2006-07-27 GT GT200600336A patent/GT200600336A/es unknown
- 2006-07-27 JP JP2008524136A patent/JP5185114B2/ja not_active Expired - Fee Related
- 2006-07-27 TW TW095127519A patent/TW200734302A/zh unknown
- 2006-07-27 RU RU2007148077/04A patent/RU2007148077A/ru not_active Application Discontinuation
- 2006-07-27 MX MX2008001338A patent/MX2008001338A/es active IP Right Grant
- 2006-07-27 US US11/494,226 patent/US7291643B2/en not_active Expired - Fee Related
- 2006-07-27 AR ARP060103257A patent/AR056005A1/es not_active Application Discontinuation
- 2006-07-27 AU AU2006275833A patent/AU2006275833B2/en not_active Ceased
- 2006-07-27 KR KR1020087002371A patent/KR20080031915A/ko not_active Ceased
- 2006-07-27 CA CA002612977A patent/CA2612977A1/en not_active Abandoned
- 2006-07-29 SA SA06270246A patent/SA06270246B1/ar unknown
-
2007
- 2007-12-20 IL IL188314A patent/IL188314A/en not_active IP Right Cessation
- 2007-12-20 CR CR9627A patent/CR9627A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076683A patent/NO20076683L/no not_active Application Discontinuation
-
2008
- 2008-01-28 EC EC2008008147A patent/ECSP088147A/es unknown
- 2008-01-28 HN HN2008000135A patent/HN2008000135A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009502947A (ja) | 2009-01-29 |
| PE20070404A1 (es) | 2007-05-10 |
| IL188314A0 (en) | 2008-04-13 |
| CR9627A (es) | 2008-03-06 |
| AU2006275833B2 (en) | 2012-04-26 |
| KR20080031915A (ko) | 2008-04-11 |
| RU2007148077A (ru) | 2009-09-10 |
| IL188314A (en) | 2012-09-24 |
| TW200734302A (en) | 2007-09-16 |
| ECSP088147A (es) | 2008-02-20 |
| UA92500C2 (ru) | 2010-11-10 |
| US7291643B2 (en) | 2007-11-06 |
| BRPI0614412A2 (pt) | 2016-11-22 |
| NO20076683L (no) | 2008-02-04 |
| US20070027126A1 (en) | 2007-02-01 |
| JP5185114B2 (ja) | 2013-04-17 |
| HN2008000135A (es) | 2010-08-19 |
| GT200600336A (es) | 2007-05-28 |
| EP1910285A1 (en) | 2008-04-16 |
| MX2008001338A (es) | 2008-03-25 |
| AU2006275833A1 (en) | 2007-02-08 |
| SA06270246B1 (ar) | 2010-11-22 |
| CA2612977A1 (en) | 2007-02-08 |
| CN101233104A (zh) | 2008-07-30 |
| WO2007016212A1 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2580481T3 (es) | Derivados de aminoquinazolina y sus sales, y métodos de uso | |
| ECSP21077887A (es) | Protacs que degradan el receptor de estrógeno | |
| BRPI0917315B8 (pt) | anticorpo monoclonal, seu uso e composição farmacêutica o compreendendo | |
| AR026122A1 (es) | Derivados de 3(5)-amino-pirazol, procedimiento para su preparacion y su uso como agente antitumorales | |
| AR046422A1 (es) | Acidos carboxilicos macrociclicos y acilsulfonamidas como inhibidores de la replicacion del vhc | |
| AR061475A1 (es) | Compuestos peptidicos para tratar status epilepticus refractario | |
| AR049399A1 (es) | Difenilimidazopirimidina e -imidazol aminas como inhibidores de b-secretasa y metodo de obtencion de los mismos | |
| AR083339A1 (es) | Compuestos de quinazolina como bloqueadores de los canales de sodio | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| TR201907575T4 (tr) | Hayvan parazitlerini kontrol etmeye yönelik faydalı ajanlar olarak aminobenzamid türevleri. | |
| BR112012023139A2 (pt) | composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma. | |
| UY29803A1 (es) | Derivados de adeninas, composiciones farmacéuticas conteniéndolos, procedimientos de preparación y aplicaciones | |
| AR052771A1 (es) | Pirimidinas biciclicas inhibidoras del vhc | |
| AR035885A1 (es) | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| EA201270738A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
| UY29316A1 (es) | Miméticos de glucocorticoides, métodos para prepararlos, composiciones farmacéuticas, y usos de los mismos. | |
| WO2007138110A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| EA201171363A1 (ru) | Новые замещенные производные индазола и азаиндазола в качестве модуляторов гамма-секретазы | |
| AR056005A1 (es) | Cianopirrol - sulfonamidas moduladores del receptor de progesterona y usos de los mismos | |
| AR114325A1 (es) | Péptidos de la cadena b de la relaxina lipidados modificados y su uso terapéutico | |
| AR068625A1 (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas | |
| AR054482A1 (es) | Derivados de azetidinona para el tratamiento de hiperlipidemias | |
| AR058338A1 (es) | Derivados de pirrol fusionado, composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la quinasa. | |
| RU2016110247A (ru) | Аналоги циклоспорина для предупреждения или лечения гепатита с | |
| AR046992A1 (es) | Derivados de espiro-dihidrobenzofuranos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |